首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
考研
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
admin
2022-12-09
43
问题
Read the following text and match each of the numbered items in the left column to its corresponding information in the right column. There are two extra choices in the right column. Mark your answers on the ANSWER SHEET.
In a state-of-the-art clean room, a scientist clad in a full-body containment suit, a hair net and blue gloves is preparing some printing cartridges—filled not with ink but a viscous milky liquid. Next to her sits a computer connected to a machine that resembles a large ice-cream dispenser, except that each of its two nozzles is made of a syringe with a long needle. Once the scientist clicks on the "run program" button, the needles squeeze not a vanilla or chocolate flavoured treat, but a paste of living cells.
Forty minutes later, the task is finished. Depending on the choice of bioink and printing pattern, the result could have been any number of three-dimensional biological structures. In this case, it is a strand of living lung tissue about 4cm in length and containing about 50m cells.
Since its start in 2007, researchers at San Diego-based Organovo have experimented with printing a wide variety of tissues, including bits of lung, kidney and heart muscle. Now the world’s first publicly traded 3D bioprinting company is gearing up for production. In January samples of its first product—slivers of human liver tissue—were delivered to an outside laboratory for testing. These are printed in sets of 24 and take about 30 minutes to produce, says Keith Murphy, the firm’s chief executive. Later this year Organovo aims to begin commercial sales.
Each set consists of a plate with 24 wells containing a piece of liver tissue 3mm square and 0.5mm deep. Although prices have not been fixed, a set of tissues like this can sell for $2,000 or more for laboratory use. It might seem expensive, but it could save pharmaceutical companies a lot of money. This is because Organovo’s research indicates that the slivers of liver respond to drugs in many ways like a fully grown human liver would. If this is confirmed by outside testing, researchers could use the printed tissues to test the toxicity of new drugs before deciding whether to embark on expensive clinical trials with patients.
The invention of 3D printing in the 1980s provided a technology now used to manufacture everything from aircraft parts to prosthetic limbs. But the promise of 3D bioprinting is even larger: to create human tissues—layer by layer—for research, drug development and testing, and ultimately as replacement organs, such as a kidney or pancreas, for patients desperately in need of a transplant. Bioprinted organs could be made from patients’ own cells and thus would not be rejected by their immune systems. They could also be manufactured on demand.
At present only a handful of companies are trying to commercialize the production of bioprinted tissues. But Thomas Boland, an early pioneer in the field, says that plenty of others are interested and estimates that about 80 teams at research institutions around the world are now trying to print small pieces of tissues as varied as skin, cartilage, blood vessels, liver, lung and heart. "It’s a wonderful technology to build three-dimensional biological structures," says Gabor Forgacs, who co-founded Organovo in 2007 and was the company’s scientific mastermind.
[A] would be made on the need of the market.
[B] said that bioprinting was a wonderful technology.
[C] could be made from the cells of patients’ relatives.
[D] claimed that it took a short time to print the tissues.
[E] showed that the printed tissues were similar to real tissues.
[F] reckoned that bioprinting appealed to a majority of companies.
[G] conducted a large number of experimental studies of bioprinting.
Keith Murphy
选项
答案
D
解析
根据Keith Murphy定位至第三段。第四句说These are printed in sets of 24 and take about 30 minutes to produce, says Keith Murphy, the firm’s chief executive (这些肝脏组织以每套24个单位打印出来,需要耗时约30分钟来制造,公司首席执行官基思.墨菲说道)。与之接近的是D项。其中,claimed对应says;took a short time对应take about 30 minutes;to print对应to produce。故本题答案为D项。
转载请注明原文地址:https://kaotiyun.com/show/eQMD777K
0
考研英语二
相关试题推荐
Peoplegenerallyassumethatwhentheyconsideranotherpersona"friend,"thatpersonalsothinksofthemasafriend,whichme
[A]Workforyourdream[B]Apennysavedisapennyearned[C]Don’tcompareyourselftoothers[D]Betruetoyou
Americahaslongbeenresistanttoadequatepovertypoliciesbecauseofitsstrongstrainofthinkingthatthepoorareresponsi
Writeanessaybasedonthechartbelow.Inyourwriting,youshould1)interpretthechart,and2)giveyourcomments.Youshou
WhatComesNextAftertheDeathofFreeMarket?WhentheCovid-19pandemicstruck,worldmarketscametoastandstill.Gover
"Universalhistory,thehistoryofwhatmanhasaccomplishedinthisworld,isatbottomtheHistoryoftheGreatMenwhohavew
EnrollmentinLosAngelespublicschoolsisexpectedtoplungebynearly30%overthenextdecade,leadingtotoughchoicesahea
Inflationisn’tnew,butpricerisescanstillshock.IrecentlyholidayedintheHamptons,atonybeachareaoutsideNewYork,
Peoplehavebeenholdingheateddiscussionsrecentlyaboutwomen’sexperienceintheworkplace.LastmonthSherylSandberg,chie
Peoplehavebeenholdingheateddiscussionsrecentlyaboutwomen’sexperienceintheworkplace.LastmonthSherylSandberg,chie
随机试题
成人常见的结核为何类型儿童常见的肺结核为何类型
在牙周诊疗中收集病史时,应常规询问的重要疾病是
政策性住房贷款的特点有()。
为了有效实施宏观调控政策,要建立健全宏观调控体系,包括()。
重大资产重组中相关资产以资产评估结果作为定价依据的,上市公司董事会应当对()发表明确意见。
郝大爷过马路时不幸摔倒昏迷,所幸有小伙子及时将他送往医院救治。郝大爷病情稳定后,有4位陌生的小伙陈安、李康、张幸、汪福来医院看望他。郝大爷问他们究竟是谁送他来医院的,他们的回答如下:陈安:我们4人都没有送您来医院。李康:我们4人中有人送您来医院。张幸
Whatdoes"impasse"probablymean?Whatdoes"reprogramminghiscomputer"meaninthelastsentenceofthepassage?
Whatdoesthemansayaboutbeersincethe1990s?
A、Hekeepstheeggwarm.B、Hegathersfoodforthefemale.C、Hebuildsanestfortheegg.D、Hedefendsthecolony.A选项中的He,keep
TheU.S.andChinadon’tagreeonmuchthesedays.GermanyandFranceshareaborderandacurrencybutarefrequentlyatodds.
最新回复
(
0
)